Short Interest Coverage: Biomerica Incorporated (NASDAQ:BMRA) Has Increase in Shorts

November 28, 2016 - By Clifton Ray   ·   0 Comments

Short Interest Coverage: Biomerica Incorporated (NASDAQ:BMRA) Has Increase in Shorts

The stock of Biomerica Incorporated (NASDAQ:BMRA) registered an increase of 8.57% in short interest. BMRA’s total short interest was 7,600 shares in November as published by FINRA. Its up 8.57% from 7,000 shares, reported previously. With 12,600 shares average volume, it will take short sellers 1 days to cover their BMRA’s short positions. The short interest to Biomerica Incorporated’s float is 0.15%. The stock decreased 3.79% or $0.08 on November 25, hitting $2.03. Biomerica, Inc. (NASDAQ:BMRA) has risen 26.09% since April 25, 2016 and is uptrending. It has outperformed by 20.07% the S&P500.

Biomerica, Inc. is a biomedical company, which develops, makes and markets medical diagnostic products for the early detection and monitoring of chronic diseases and medical conditions. The company has a market cap of $16.61 million. The Company’s medical diagnostic products are sold around the world in over two markets, including clinical laboratories and point of care . It currently has negative earnings. The Firm operates in Europe, the United States, Asia, South America, the Middle East and other foreign countries.

BMRA Company Profile

Biomerica, Inc., incorporated on September 22, 1971, is a biomedical company, which develops, makes and markets medical diagnostic products for the early detection and monitoring of chronic diseases and medical conditions. The Company’s medical diagnostic products are sold around the world in over two markets, including clinical laboratories and point of care (physicians’ offices and over-the-counter drugstores). The Firm operates in Europe, the United States, Asia, South America, the Middle East and other foreign countries. The Company’s diagnostic test kits are used to analyze blood, urine or fecal specimens from patients in the diagnosis of various diseases and other medical complications, or to measure the level of specific hormones, antibodies, antigens or other substances, which exist in the human body in various concentrations.

More news for Biomerica, Inc. (NASDAQ:BMRA) were recently published by: Streetinsider.com, which released: “Biomerica, Inc. (BMRA) Cleared to List on Nasdaq CM” on August 24, 2016. Streetinsider.com‘s article titled: “Form 4 BIOMERICA INC For: Nov 17 Filed by: Irani Zackary S.” and published on November 21, 2016 is yet another important article.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

By Clifton Ray


Readers Comments (0)





Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our FREE daily email newsletter:


Recent Market News

>